JP2015524406A5 - - Google Patents

Download PDF

Info

Publication number
JP2015524406A5
JP2015524406A5 JP2015522181A JP2015522181A JP2015524406A5 JP 2015524406 A5 JP2015524406 A5 JP 2015524406A5 JP 2015522181 A JP2015522181 A JP 2015522181A JP 2015522181 A JP2015522181 A JP 2015522181A JP 2015524406 A5 JP2015524406 A5 JP 2015524406A5
Authority
JP
Japan
Prior art keywords
formula
acid
compound
solvate
reaction mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015522181A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015524406A (ja
JP6236446B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2013/001538 external-priority patent/WO2014013311A1/en
Publication of JP2015524406A publication Critical patent/JP2015524406A/ja
Publication of JP2015524406A5 publication Critical patent/JP2015524406A5/ja
Application granted granted Critical
Publication of JP6236446B2 publication Critical patent/JP6236446B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015522181A 2012-07-16 2013-07-15 改善されたオピオイド合成方法 Active JP6236446B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261672265P 2012-07-16 2012-07-16
US61/672,265 2012-07-16
US201361762657P 2013-02-08 2013-02-08
US61/762,657 2013-02-08
PCT/IB2013/001538 WO2014013311A1 (en) 2012-07-16 2013-07-15 Process for improved opioid synthesis

Publications (3)

Publication Number Publication Date
JP2015524406A JP2015524406A (ja) 2015-08-24
JP2015524406A5 true JP2015524406A5 (enExample) 2016-08-18
JP6236446B2 JP6236446B2 (ja) 2017-11-22

Family

ID=48916126

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015522181A Active JP6236446B2 (ja) 2012-07-16 2013-07-15 改善されたオピオイド合成方法

Country Status (21)

Country Link
US (4) US20150259355A1 (enExample)
EP (1) EP2877473B1 (enExample)
JP (1) JP6236446B2 (enExample)
KR (1) KR101946104B1 (enExample)
CN (1) CN104507947B (enExample)
AR (1) AR091779A1 (enExample)
AU (2) AU2013291723B2 (enExample)
BR (1) BR112015000867A2 (enExample)
CA (1) CA2879268C (enExample)
CO (1) CO7180189A2 (enExample)
EA (1) EA029925B1 (enExample)
ES (1) ES2638178T3 (enExample)
IL (1) IL236711B (enExample)
IN (1) IN2015DN01164A (enExample)
MX (1) MX362186B (enExample)
NZ (2) NZ628695A (enExample)
PH (1) PH12015500088B1 (enExample)
SG (1) SG11201407986QA (enExample)
TW (2) TW201639855A (enExample)
UA (1) UA117226C2 (enExample)
WO (1) WO2014013311A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR091779A1 (es) 2012-07-16 2015-02-25 Rhodes Technologies Procedimiento para la sintesis mejorada de opioides
UA117225C2 (uk) * 2012-07-16 2018-07-10 Родес Текнолоджіс Спосіб покращеного синтезу опіоїду
US9062062B1 (en) 2013-12-18 2015-06-23 Cody Laboratories, Inc. Synthesis of oxycodone hydrochloride
CA2934527A1 (en) * 2013-12-18 2015-06-25 Cody Laboratories, Inc. Synthesis of oxycodone hydrochloride
US10227354B2 (en) 2013-12-18 2019-03-12 Cody Laboratories, Inc. Conversion of oxycodone base to oxycodone hydrochloride
US8846923B1 (en) 2013-12-18 2014-09-30 Cody Laboratories, Inc. Preparation of 14-hydroxycodeinone sulfate
KR101868724B1 (ko) 2014-01-15 2018-06-18 로드스 테크놀로지즈 개선된 옥시모르폰 합성을 위한 방법
JP2017502991A (ja) 2014-01-15 2017-01-26 ローズ テクノロジーズ 改良されたオキシコドン合成のための方法
US20160052932A1 (en) * 2014-08-25 2016-02-25 Johnson Matthey Public Limited Company Processes for Making Opioids Including 14-Hydroxycodeinone and 14-hydroxymorphinone
CN110770238B (zh) 2017-06-20 2022-10-04 庄信万丰股份有限公司 用于从14-羟可待因酮制备盐酸氧可酮的氢化方法
KR102445512B1 (ko) 2018-03-30 2022-09-21 삼성디스플레이 주식회사 지문 센서 패키지 및 이를 포함하는 표시 장치
KR102120720B1 (ko) * 2018-07-16 2020-06-10 연성정밀화학(주) 날푸라핀 함유 구강붕해정
CN114573508B (zh) * 2020-12-01 2024-07-23 绍兴赜军生物医药科技有限公司 羟考酮类化合物、其中间体及制备方法
US11247999B1 (en) 2021-07-02 2022-02-15 Joseph DeGraw Facile conversion of morphine to normorphine
CN114276358B (zh) * 2022-01-07 2023-09-12 北京华素制药股份有限公司 羟考酮盐酸盐的多晶型物及其制备方法和用途
WO2025174540A1 (en) * 2024-02-17 2025-08-21 The Regents Of The University Of California Novel morphine framework derivatives

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2772270A (en) 1954-10-21 1956-11-27 M J Lewenstein 14-hydroxymorphinone and 8, 14-dihydroxydihydromorphinone
US3173876A (en) 1960-05-27 1965-03-16 John C Zobrist Cleaning methods and compositions
NL271831A (enExample) 1960-11-29
US3276586A (en) 1963-08-30 1966-10-04 Rosaen Filter Co Indicating means for fluid filters
NL6714885A (enExample) 1967-11-02 1969-05-06
US3541006A (en) 1968-07-03 1970-11-17 Amicon Corp Ultrafiltration process
US3541005A (en) 1969-02-05 1970-11-17 Amicon Corp Continuous ultrafiltration of macromolecular solutions
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
GB1478759A (en) 1974-11-18 1977-07-06 Alza Corp Process for forming outlet passageways in pills using a laser
US4077407A (en) 1975-11-24 1978-03-07 Alza Corporation Osmotic devices having composite walls
US4063064A (en) 1976-02-23 1977-12-13 Coherent Radiation Apparatus for tracking moving workpiece by a laser beam
US4285987A (en) 1978-10-23 1981-08-25 Alza Corporation Process for manufacturing device with dispersion zone
US4200098A (en) 1978-10-23 1980-04-29 Alza Corporation Osmotic system with distribution zone for dispensing beneficial agent
US4861598A (en) 1986-07-18 1989-08-29 Euroceltique, S.A. Controlled release bases for pharmaceuticals
DE3812567A1 (de) 1988-04-15 1989-10-26 Basf Ag Verfahren zur herstellung pharmazeutischer mischungen
US5215758A (en) 1991-09-11 1993-06-01 Euroceltique, S.A. Controlled release matrix suppository for pharmaceuticals
US5472712A (en) 1991-12-24 1995-12-05 Euroceltique, S.A. Controlled-release formulations coated with aqueous dispersions of ethylcellulose
US5273760A (en) 1991-12-24 1993-12-28 Euroceltigue, S.A. Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
US5286493A (en) 1992-01-27 1994-02-15 Euroceltique, S.A. Stabilized controlled release formulations having acrylic polymer coating
US5324351A (en) 1992-08-13 1994-06-28 Euroceltique Aqueous dispersions of zein and preparation thereof
CA2454328C (en) * 2001-07-18 2008-03-18 Christopher D. Breder Pharmaceutical combinations of oxycodone and naloxone
US6864370B1 (en) * 2003-06-05 2005-03-08 Zhaiwei Lin Process for manufacturing oxycodone
US20050203115A1 (en) * 2004-03-10 2005-09-15 Sancilio Frederick D. Narcotic-NSAID ion pairs
TWI365880B (en) * 2004-03-30 2012-06-11 Euro Celtique Sa Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone and oxycodone hydrochloride composition,pharmaceutical dosage form,sustained release oeal dosage form and pharmaceutically acceptable package having less than 25 pp
SK286087B6 (sk) * 2004-08-18 2008-03-05 Zentiva, A. S. Spôsob prípravy oxykodonu
GB0421149D0 (en) 2004-09-23 2004-10-27 Johnson Matthey Plc Preparation of oxycodone
SK286233B6 (sk) 2004-11-15 2008-05-06 Zentiva, A. S. Spôsob izolácie 14-hydroxykodeinonu
CA2614223A1 (en) * 2005-02-24 2006-08-31 Dr Pharma Nova, Llc A registry method and control system for dea schedule ii-v medicines
ES2357216T3 (es) 2005-06-16 2011-04-20 Mallinckrodt, Inc. Una ruta de síntesis de 14-hidroxil-opiáceos a través de 1-halo-tebaína o análogos.
KR100753432B1 (ko) 2005-11-08 2007-08-31 경희대학교 산학협력단 다결정 실리콘 및 그의 결정화 방법
US20070117826A1 (en) * 2005-11-23 2007-05-24 Forest Laboratories, Inc. Pharmaceutical formulations comprising ibuprofen, oxycodone, and 14-hydroxycodeinone
CN101395159A (zh) 2006-03-02 2009-03-25 马林克罗特公司 制备含有低含量α,β-不饱和酮化合物的吗啡烷-6-酮产物的方法
CA2671518C (en) * 2006-12-04 2016-06-07 Noramco, Inc. Process for preparing oxycodone having reduced levels of 14-hydroxycodeinone
ES2378710T3 (es) 2006-12-04 2012-04-17 Noramco, Inc. Procedimiento para reducir impurezas en la base de oxicodona
GB0624880D0 (en) 2006-12-14 2007-01-24 Johnson Matthey Plc Improved method for making analgesics
CA2681740A1 (en) 2007-03-23 2008-10-02 Mallinckrodt Inc. Improved preparation of oxymorphone from oripavine
ES2423180T3 (es) * 2007-04-16 2013-09-18 Mallinckrodt Llc Nueva reducción de opiáceos mediante reacción de transferencia de hidrógeno catalítica
GB2450691A (en) 2007-07-02 2009-01-07 Alpharma Aps One-pot preparation of oxycodone from thebaine
US8217204B2 (en) 2009-06-03 2012-07-10 Takasago International Corporation Catalyst for asymmetric hydrogenation
WO2011032214A1 (en) 2009-09-16 2011-03-24 Monash University A method for the n-demethylation of n-methyl heterocycles
EP2377866B1 (en) * 2010-03-23 2014-02-26 Siegfried AG Preparation of low impurity opiates in a continuous flow reactor
TWI471289B (zh) 2010-06-11 2015-02-01 Rhodes Technologies 使三級胺進行n-脫烷反應之方法
EP2588481B1 (en) * 2010-07-02 2017-11-15 Johnson Matthey Public Limited Company Process for the synthesis and purification of oxycodone
JP5728084B2 (ja) 2010-07-08 2015-06-03 アルカーメス ファーマ アイルランド リミテッド 置換モルフィナンの合成のための方法
JP5780933B2 (ja) 2010-12-01 2015-09-16 高砂香料工業株式会社 光学活性メントールの製造方法
WO2013188418A1 (en) 2012-06-11 2013-12-19 Jianguang Sun Improved method of preparing oxymorphone
UA117225C2 (uk) 2012-07-16 2018-07-10 Родес Текнолоджіс Спосіб покращеного синтезу опіоїду
AR091779A1 (es) 2012-07-16 2015-02-25 Rhodes Technologies Procedimiento para la sintesis mejorada de opioides
CN103113378B (zh) 2013-02-20 2016-04-06 北京华素制药股份有限公司 一种盐酸羟吗啡酮的合成方法
CN103433076B (zh) 2013-09-02 2015-06-24 浙江新和成股份有限公司 一种固载型不对称催化剂及其在不对称氢化反应中的应用
US9060620B1 (en) 2013-12-04 2015-06-23 Yogi Realty LLC Baby restraining article
CA2934527A1 (en) 2013-12-18 2015-06-25 Cody Laboratories, Inc. Synthesis of oxycodone hydrochloride
US10227354B2 (en) 2013-12-18 2019-03-12 Cody Laboratories, Inc. Conversion of oxycodone base to oxycodone hydrochloride
US8846923B1 (en) 2013-12-18 2014-09-30 Cody Laboratories, Inc. Preparation of 14-hydroxycodeinone sulfate
US9062062B1 (en) 2013-12-18 2015-06-23 Cody Laboratories, Inc. Synthesis of oxycodone hydrochloride
JP2017502991A (ja) 2014-01-15 2017-01-26 ローズ テクノロジーズ 改良されたオキシコドン合成のための方法
KR101868724B1 (ko) 2014-01-15 2018-06-18 로드스 테크놀로지즈 개선된 옥시모르폰 합성을 위한 방법

Similar Documents

Publication Publication Date Title
JP2015524406A5 (enExample)
JP2015524407A5 (enExample)
JP2011037841A5 (enExample)
JP2013249315A5 (enExample)
WO2012051412A3 (en) Process for recovering halogen promoters and removing permanganate reducing compounds
JP2019048806A5 (enExample)
JP2013539448A5 (enExample)
JP2013508368A5 (enExample)
JPWO2016098699A1 (ja) カルボン酸エステルの製造方法
JP2010505861A5 (enExample)
CN108290834B (zh) 硫代羧酸酯的制造方法
JP2011529942A5 (enExample)
JP2013506719A5 (enExample)
RU2018100967A (ru) Способ получения азотсодержащего гетероциклического соединения и его промежуточного соединения
JP2017509581A5 (enExample)
JP2017516808A5 (enExample)
JP2017533926A5 (enExample)
JP2013541147A5 (enExample)
TW201522289A (zh) 1,2,3-三亞基三(氰甲基亞基)三(2,3,5,6-四氟苯甲腈)環丙烷程序
JP2006188509A5 (enExample)
JP2012062307A5 (enExample)
TW201613856A (en) Method for producing harmful-organism control agent, and intermediate thereof
JP2014520796A5 (enExample)
JP2014520066A5 (enExample)
JP2008540655A5 (enExample)